Basel Medical Group Ltd (BMGL)

Basel Medical Group Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	2.98	1.95	1.22	1.56
Cash & Short-Term Investments	2.98	1.95	1.22	1.56
Cash Growth	52.69%	60.26%	-22.14%	-
Accounts Receivable	9.73	2.01	1.58	2.28
Other Receivables	-	10.56	11.88	11.75
Total Trade Receivables	9.73	12.56	13.46	14.03
Inventory	0.38	0.07	0.09	0.07
Other Current Assets	0.03	1.59	-	-
Total Current Assets	13.12	16.17	14.77	15.67
Net Property, Plant & Equipment	3.45	0.06	0.58	1.18
Long-Term Investments	0	-	-	-
Other Long-Term Assets	0.28	0.08	0.03	0
Total Assets	16.85	16.31	15.38	16.85
Accounts Payable	6.91	2.58	2.19	2.41
Short-Term Debt	2.12	2.71	3.79	4.2
Other Current Liabilities	1.66	1.88	0.49	0.58
Total Current Liabilities	10.69	7.16	9.89	7.19
Long-Term Debt	1.3	1.58	3.42	5.95
Total Long-Term Liabilities	1.3	1.58	3.42	5.95
Total Liabilities	11.99	8.75	13.32	13.14
Common Stock	34.21	24.46	0	0
Accumulated Other Comprehensive Income	-24.95	-24.46	-	-
Retained Earnings	-4.4	7.56	5.49	3.71
Total Common Shareholders' Equity	4.86	7.56	5.49	3.71
Minority Interest	0	-	-	-
Shareholders' Equity	4.86	7.56	5.49	3.71
Total Liabilities & Equity	16.85	16.31	15.38	16.85
Total Debt	3.42	4.29	7.21	10.15
Net Cash (Debt)	-0.44	-2.34	-6	-8.59
Net Cash Per Share	-0.02	-0.14	-0.37	-0.53
Book Value	4.86	7.56	5.49	3.71
Book Value Per Share	0.26	0.47	0.34	0.23
Tangible Book Value	4.86	7.56	5.49	3.71
Tangible Book Value Per Share	0.26	0.47	0.34	0.23

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q